Literature DB >> 31621833

Why did remote ischaemic conditioning not improve clinical outcomes in acute myocardial infarction in the CONDI-2/ERIC-PPCI trial?

Derek J Hausenloy1,2,3,4,5,6, Hans Erik Bøtker7.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31621833     DOI： 10.1093/cvr/cvz242

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN： 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  7 in total

1.  Neuroprotection by remote ischemic conditioning in the setting of acute ischemic stroke: a preclinical two-centre study.

Authors:  Maryna V Basalay; Marlene Wiart; Fabien Chauveau; Chloe Dumot; Christelle Leon; Camille Amaz; Radu Bolbos; Diana Cash; Eugene Kim; Laura Mechtouff; Tae-Hee Cho; Norbert Nighoghossian; Sean M Davidson; Michel Ovize; Derek M Yellon
Journal:  Sci Rep       Date:  2020-10-09       Impact factor: 4.379

2.  Repeated Remote Ischemic Conditioning Reduces Doxorubicin-Induced Cardiotoxicity.

Authors:  Quan He; Fangfei Wang; Thomas D Ryan; Meghana Chalasani; Andrew N Redington
Journal:  JACC CardioOncol       Date:  2020-03-17

3.  Remote Ischaemic Conditioning in STEMI Patients in Sub-Saharan AFRICA: Rationale and Study Design for the RIC-AFRICA Trial.

Authors:  Kishal Lukhna; Derek J Hausenloy; Abdelbagi Sidahmed Ali; Abdullah Bajaber; Alistair Calver; Arthur Mutyaba; Awad Abdalla Mohamed; Brian Kiggundu; Chishala Chishala; Ebrahim Variava; Ehab Ali Elmakki; Elijah Ogola; Eltayeb Hamid; Emmy Okello; Isam Gaafar; Keiran Mwazo; Makoali Makotoko; Mergan Naidoo; Mohamed Elhadi Abdelhameed; Motasim Badri; Nasief van der Schyff; Omaima Abozaid; Paul Xafis; Sara Giesz; Trevor Gould; Waldo Welgemoed; Malcolm Walker; Mpiko Ntsekhe; Derek M Yellon
Journal:  Cardiovasc Drugs Ther       Date:  2021-11-05       Impact factor: 3.947

4.  Effect of remote ischaemic conditioning on infarct size and remodelling in ST-segment elevation myocardial infarction patients: the CONDI-2/ERIC-PPCI CMR substudy.

Authors:  Rohin Francis; Jun Chong; Heerajnarain Bulluck; Derek J Hausenloy; Manish Ramlall; Chiara Bucciarelli-Ducci; Tim Clayton; Matthew Dodd; Thomas Engstrøm; Richard Evans; Vanessa M Ferreira; Marianna Fontana; John P Greenwood; Rajesh K Kharbanda; Won Yong Kim; Tushar Kotecha; Jacob T Lønborg; Anthony Mathur; Ulla Kristine Møller; James Moon; Alexander Perkins; Roby D Rakhit; Derek M Yellon; Hans Erik Bøtker
Journal:  Basic Res Cardiol       Date:  2021-10-14       Impact factor: 17.165

5.  Does Disruption of Optic Atrophy-1 (OPA1) Contribute to Cell Death in HL-1 Cardiomyocytes Subjected to Lethal Ischemia-Reperfusion Injury?

Authors:  Andrew R Kulek; Vishnu V R Undyala; Anthony R Anzell; Sarita Raghunayakula; Lee Ann MacMillan-Crow; Thomas H Sanderson; Karin Przyklenk
Journal:  Cells       Date:  2022-09-30       Impact factor: 7.666

Review 6.  Mitochondria in acute myocardial infarction and cardioprotection.

Authors:  Chrishan J A Ramachandra; Sauri Hernandez-Resendiz; Gustavo E Crespo-Avilan; Ying-Hsi Lin; Derek J Hausenloy
Journal:  EBioMedicine       Date:  2020-07-10       Impact factor: 8.143

7.  Differences in intrinsic aerobic capacity alters sensitivity to ischemia-reperfusion injury but not cardioprotective capacity by ischemic preconditioning in rats.

Authors:  Marie Vognstoft Hjortbak; Thomas Skjærlund Grønnebæk; Nichlas Riise Jespersen; Thomas Ravn Lassen; Jacob Marthinsen Seefeldt; Pernille Tilma Tonnesen; Rebekka Vibjerg Jensen; Lauren Gerard Koch; Steven L Britton; Michael Pedersen; Niels Jessen; Hans Erik Bøtker
Journal:  PLoS One       Date:  2020-10-27       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.